FDA OKs Immunicon's rare cell collection tube
This article was originally published in Clinica
Cancer diagnostic firm Immunicon has received US FDA clearance to market a blood collection tube that preserves circulating tumour cells. The New York company believes its CellSave preservative tube to be the only one of its kind currently available. A spokesperson for the firm told Clinica: "To our knowledge there is no such 'draw tube' on the market today for preserving circulating tumour cells, which have potential medical utility in the management of cancer patients."